Broad regulator support encourages WHO to pursue 'biological qualifier' plan
This article was originally published in Scrip
The World Health Organization is pressing on with its proposal for a "biological qualifier" (BQ) after its group of experts decided the plan had garnered sufficient support from stakeholders including drug regulatory authorities and industry.
You may also be interested in...
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.
The EU’s new health commissioner, Stella Kyriakides, has outlined the commission’s plans for dealing with medicines access issues in the EU member states. They include completing the review of the EU pediatric and orphan legislation and developing a new strategic plan to tackle shortages and affordability problems next year.
AstraZeneca’s Lynparza can now be used on the Scottish National Health Service for newly diagnosed advanced ovarian cancer.